2010
DOI: 10.4049/jimmunol.0903873
|View full text |Cite
|
Sign up to set email alerts
|

Cutting Edge: Granulocyte-Macrophage Colony-Stimulating Factor Is the Major CD8+ T Cell-Derived Licensing Factor for Dendritic Cell Activation

Abstract: Material

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
58
1

Year Published

2011
2011
2014
2014

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 70 publications
(63 citation statements)
references
References 20 publications
4
58
1
Order By: Relevance
“…Upregulation of both molecules was further increased in the presence of GM-CSF (Fig. 6A), corroborating the previous studies [19,28]. However, this upregulation of activation molecules in GM-CSF licensed DCs can only explain the augmented ability of splenic DCs to support T-cell proliferation, since thymic DCs did not require licensing to induce efficient T-cell proliferation, and both freshly isolated and cultured thymic and splenic CD8 1 DCs showed no major difference in the expression of CD80 and CD86 (Figs.…”
Section: Thymic Cd103supporting
confidence: 92%
See 2 more Smart Citations
“…Upregulation of both molecules was further increased in the presence of GM-CSF (Fig. 6A), corroborating the previous studies [19,28]. However, this upregulation of activation molecules in GM-CSF licensed DCs can only explain the augmented ability of splenic DCs to support T-cell proliferation, since thymic DCs did not require licensing to induce efficient T-cell proliferation, and both freshly isolated and cultured thymic and splenic CD8 1 DCs showed no major difference in the expression of CD80 and CD86 (Figs.…”
Section: Thymic Cd103supporting
confidence: 92%
“…This discrepancy may be due to the fact that in the previous studies, ex vivo cross-priming assays have been performed in the presence of GM-CSF and/or DCs have been isolated from Flt3 ligand-treated mice. Accordingly, it has been recently demonstrated that, similar to CD40 ligand, GM-CSF is a licensing factor that activates DCs [19]. To explore this possibility, we performed T-cell proliferation assays in the presence of GM-CSF, and found that in this situation splenic CD8 1 DCs were indeed able to efficiently cross-prime and induce proliferation of 8078% of OT-I cells, which is comparable to the efficiency of the thymic CD8 1 DCs (Fig.…”
mentioning
confidence: 71%
See 1 more Smart Citation
“…GM-CSF can be produced by macrophages but, interestingly, apparently not by DC (49). In vivo, ongoing DC recruitment and differentiation in the setting of tissue inflammation may be highly dependent on other cell types (28) and the supply of critical cytokines such as GM-CSF (51,52 findings of previous reports (36,37) that show normal cDC development and function in Nfkb1 2/2 mice, with a marginal reduction in numbers being the main difference to WT mice. Importantly, we found MoDC in the directly involved joint tissue of WT mice with inflammatory arthritis, and MoDC were identified as a likely target for CD4 T cell-derived GM-CSF.…”
Section: Discussionmentioning
confidence: 79%
“…T cells appear to lack GM-CSF receptors; thus, this effect was most likely via enhancement of IL-6 and IL-23 production from APC. Although it was previously thought that GM-CSF 2/2 mice had normal DC (50), GM-CSF was recently found to be required for the accumulation of Langerin + CD103 + DC (51), and GM-CSF production by CD8 + T cells, in combination with microbial stimuli, was postulated as a "licensing factor" for DC (52). GM-CSF can be produced by macrophages but, interestingly, apparently not by DC (49).…”
Section: Discussionmentioning
confidence: 99%